Financials

  • Market Capitalization 265.4 M
  • Employee 59
  • Founded 2019
  • CEO N/A
  • Website www.sionnatx.com
  • Headquarter Delaware, United States
  • FIGI BBG016X2DC85
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-20.85
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3405
ACIU
AC Immune SA - Common Stock
2.67 USD+0.75%-5.32%+19.20%+28.37%271.65 M USD
3419
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
3.74 USD-1.58%-1.84%-21.92%+120.00%268.05 M USD
3424
TRDA
Entrada Therapeutics, Inc. - Common Stock
6.81 USD-2.71%-7.35%-0.29%-2.30%265.16 M USD
3427
AVXL
Anavex Life Sciences Corp. - Common Stock
2.85 USD-4.68%-8.95%+3.26%-70.13%264.19 M USD